Fredun Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 78.81 | 118.03 | 87.01 |
| Operating Expense | 68.33 | 106.87 | 76.49 |
| Net Profit | 4.13 | 5.06 | 4.22 |
| Net Profit Margin | 5.24 | 4.29 | 4.85 |
| Earning Per Share | 8.79 | 10.77 | 8.99 |
| EBIDTA | 10.48 | 11.17 | 10.52 |
| Effective Tax Rate | 13.26 | 6.98 | 14.64 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 78.81 |
| Operating Expense | 68.33 |
| Net Profit | 4.13 |
| Net Profit Margin | 5.24 |
| Earning Per Share | 8.79 |
| EBIDTA | 10.48 |
| Effective Tax Rate | 13.26 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 274.68 | 224.46 | 133.89 |
| Operating Expenses Annual | 246.90 | 210.66 | 125.92 |
| Operating Profit Annual | 29.60 | 15.43 | 9.37 |
| Interest Annual | 9.28 | 4.67 | 4.16 |
| Depreciation | 2.81 | 2.16 | 2.00 |
| Net Profit Annual | 10.81 | 6.34 | 2.01 |
| Tax Annual | 6.70 | 2.26 | 1.19 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 274.68 |
| Operating Expenses Annual | 246.90 |
| Operating Profit Annual | 29.60 |
| Interest Annual | 9.28 |
| Depreciation | 2.81 |
| Net Profit Annual | 10.81 |
| Tax Annual | 6.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.07 | 1.13 | 3.06 |
| Cash Flow from Operations | -14.41 | -2.38 | 0.17 |
| Cash Flow from Investing | -9.40 | -4.14 | -1.39 |
| Cash Flow from Financing | 25.18 | 7.47 | -0.71 |
| Cash Flow at the End | 3.44 | 2.07 | 1.13 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 2.07 |
| Cash Flow from Operations | -14.41 |
| Cash Flow from Investing | -9.40 |
| Cash Flow from Financing | 25.18 |
| Cash Flow at the End | 3.44 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 11.15 | 6.91 | 7.16 |
| PBIT Margin (%) | 10.13 | 5.94 | 5.66 |
| PBT Margin (%) | 9.15 | 4.69 | 4.37 |
| Net PROFIT Margin (%) | 3.94 | 2.82 | 1.50 |
| Return On Networth / Equity (%) | 13.15 | 11.41 | 4.76 |
| Return On Networth /Employed (%) | 18.11 | 12.90 | 9.34 |
| Return On Assets (%) | 7.04 | 6.13 | 2.48 |
| Total Debt / Equity (X) | 0.85 | 0.83 | 0.88 |
| Asset Turnover Ratio (%) | 1.79 | 2.17 | 1.65 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 11.15 |
| PBIT Margin (%) | 10.13 |
| PBT Margin (%) | 9.15 |
| Net PROFIT Margin (%) | 3.94 |
| Return On Networth / Equity (%) | 13.15 |
| Return On Networth /Employed (%) | 18.11 |
| Return On Assets (%) | 7.04 |
| Total Debt / Equity (X) | 0.85 |
| Asset Turnover Ratio (%) | 1.79 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 38.93 | 32.34 | 30.35 |
| Total Current Assets Annual | 216.21 | 152.65 | 130.08 |
| Non Current Assets Annual | 41.07 | 34.34 | 31.54 |
| Total Shareholders Funds Annual | 96.38 | 68.06 | 43.07 |
| Total Assets Annual | 257.28 | 186.99 | 161.62 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 38.93 |
| Total Current Assets Annual | 216.21 |
| Non Current Assets Annual | 41.07 |
| Total Shareholders Funds Annual | 96.38 |
| Total Assets Annual | 257.28 |
No Data Availabe
